Roflumilast
500 ug/1 · Tablet
By Camber Pharmaceuticals, Inc.
- NDC
- 31722-623
- Route
- Oral
- Therapeutic class
- Phosphodiesterase 4 Inhibitor , Phosphodiesterase 4 Inhibitors [MoA]
- Marketing category
- ANDA
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

